Arcturus Therapeutics Holdings Inc.
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
ARCT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US03969T1097
- LEI:
- Country:
- United States of America
- Address:
- 10628 SCIENCE CENTER DRIVE, 92121 SAN DIEGO
- Website:
- https://arcturusrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Arcturus Therapeutics Holdings Inc. is a late-stage messenger RNA (mRNA) medicines company focused on the discovery, development, and commercialization of therapeutics and vaccines. The company leverages its proprietary STARR® self-amplifying mRNA technology and LUNAR® lipid-mediated delivery platform to advance its pipeline. Its primary focus is on developing treatments for rare diseases, particularly those affecting the liver and respiratory system, such as Ornithine Transcarbamylase (OTC) deficiency and Cystic Fibrosis, as well as developing vaccines for infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Arcturus Therapeutics Holdings Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Arcturus Therapeutics Holdings Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Arcturus Therapeutics Holdings Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
